FINHUB Insights

COR · Q3 FY25 · Jun 30, 2025

Cencora Q3 FY25: where the revenue came from and where it went

Cencora Q3 FY25: revenue $80.7B (+9% year over year). Net profit $0.7B. Largest cohort US Healthcare Solutions $72.9B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jun 30, 2025
Reported
Aug 6, 2025 10-Q
Sankey diagram of Cencora's income statement for Q3 FY25: revenue of $80.7 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$80.7B +9% year over year
Gross profit$2.9B 4% margin
Operating profit$0.9B 1% margin
Net profit$0.7B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 80.7 100% +9%
US Healthcare Solutions 72.9 90% +8%
International Healthcare 7.8 10% +10%
Cost of revenue−77.896%
Gross profit2.94% margin+0pp
SG&A−1.62%+0pp
Other−0.40%+0pp
Operating profit0.91% margin+0pp
Tax−0.2
Net profit0.71%+0pp
Filing on EDGAR More quarters of COR

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters